Oslo, 25 March 2026 - Observe Medical ASA (the "Company" or "Observe Medical")
announces that its journey into the strategically important Indian market has
reached a new level through the signing of an exclusive distribution agreement
with a leading local partner. This replaces the previously announced LOI.
The partner is a historical distributor of UnoMeterT and brings deep market
knowledge, an established sales network, and strong relationships within the
Indian healthcare sector.
This agreement represents an important milestone in the Company's expansion
strategy in India, one of the largest and fastest-growing healthcare markets
globally. The partnership is expected to accelerate commercial activities and
further strengthen the Company's presence in the region.
CEO Jørgen Mann commented: "Our journey into the Indian market has now reached a
new level. By entering into an exclusive distribution agreement with a partner
that already has extensive experience within the UnoMeterT category, we are well
positioned to scale our commercial efforts and capture opportunities in this
high-growth market."
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12765
E-mail: johan.fagerli@observemedical.com
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available atwww.observemedical.com.